Skip to main content
Publications
Rebordosa C, Thomsen RW, Tave AK, Madsen M, Beachler DC, Martinez D, Garcia-Esteban R, Plana E, Tormos A, Farsani SF, Perez-Gutthann S, Pladevall-Vila M. Liver, renal, genitourinary, and diabetic ketoacidosis risks among new users of empagliflozin versus DPP-4 inhibitors in patients with type 2 diabetes: post-authorisation safety study based on multinational cohorts. Diabetes Obes Metab. 2024 Apr;26(4):1291-304. doi: 10.1111/dom.15429
Alvarez-Martin C, Ribera A, Marsal JR, Ariza-Sole A, Perez-Hoyos S, Oristrell G, Soriano-Colome T, Romaguera R, Pijoan JI, Lidon RM, Mauri J, Ferreira-Gonzalez I. Dynamics of emergency cardiovascular hospital admissions and in-hospital mortality during the COVID-19 pandemic: time series analysis and impact of socioeconomic factors. Front. Cardiovasc. Med. 2022 Apr 26. doi: 10.3389/fcvm.2022.827212